The Busiest Dealmakers Of 2022
2022 Deal-Making Led By Sanofi, J&J And Roche
With only weeks to go in 2022, the three major pharmas each had inked between 16 and 20 deals. Meanwhile, Pfizer has been less busy with 12 deals, but those include M&A totaling $18.2bn.
